{"schema":"sb.node.v1","id":"sb:e/1ee53d41c55e54b636a128d0","kind":"entity","label":{"text":"bayer","locale":"en"},"identity":{"anchor":"label:en:bayer","strength":"label"},"asOf":{"knowledgeCutoff":"2026-10-09T23:33:39.923351+00:00","snapshot":"deploy 28eb973c8e78d47cd7dc1d22314686757daeda65"},"lens":{"kind":"public"},"build":{"plane":"projected","builtFrom":["entity_graph.slim.json","entity_receipts (deploy asset)","event_graph.json","truth_records (deploy asset)","corroborated_record.json"],"rule":"node-projection.entity@v1"},"standing":{"evidence":{"supporting":99,"separatePublishers":60,"basis":"documents that mention the subject and the outlets that carried them; a mention is evidence the referent is in use, not evidence about any claim","receiptsOnTopic":{"state":"measured","share":1,"named":10,"of":10,"basis":"receipts the entity graph keeps whose own headline names the subject, over all receipts it keeps for the subject (the door's measurement; the graph carries none of its own). Only the former are served"}},"admission":{"state":"canonical","reason":"entity graph provenance 'curated'; the node carries no promotion receipt in v1","policy":"EQ-PROMOTION (receipt not carried)"},"disposition":{"state":"served","reason":"public record"},"validity":{"from":"2026-05-19","to":"2026-10-07","basis":"first and last day we saw it mentioned; not the subject's own lifetime"},"measurement":{"state":"partial","blind":["assertion coverage 0.232: about 77% of mentions carry no typed assertion"]}},"dimensions":{"domains":["auto"],"activeDays":31,"assertions":{"regulatory-approval":8,"award":4,"funding-round":3,"utterance":3,"launch-release":1,"acquisition":1}},"up":[],"upNote":"An entity is a root: it is contained by nothing. Pan out by following R.","children":{"count":10,"byKind":{"observation":10},"withheld":{"state":"withheld","count":2,"reason":"2 receipts withheld: no source link (the same rule the topic record applies)"},"items":[{"id":"sb:o/6d0f1f021d82f3e3a0ec83ca","kind":"observation","label":"Fortune · 2026-10-07 · Bayer’s CEO cut manager ranks by 70%. Now comes the hard part","url":"https://fortune.com/2026/10/07/bayer-ceo-bill-anderson-flat-reduced-managers-growth/"},{"id":"sb:o/93463b655abe5b02f87f9840","kind":"observation","label":"Chemical Engineering · 2026-10-06 · Bayer to construct new pharmaceutical manufacturing site in Ohio","url":"https://www.chemengonline.com/bayer-to-construct-new-pharmaceutical-manufacturing-site-in-ohio/"},{"id":"sb:o/b7cc3107758425a6bd253a9d","kind":"observation","label":"Area Development · 2026-10-03 · Bayer Plans New Albany, Ohio, Pharmaceutical Manufacturing Operations","url":"https://www.areadevelopment.com/newsItems/10-3-2026/bayer-new-albany-ohio.shtml"},{"id":"sb:o/98d966f2ca920d222e8fc4ae","kind":"observation","label":"Insurance Journal · 2026-10-01 · Bayer Faces Trial Test of Remaining Roundup Claims After Supreme Court Win","url":"https://www.insurancejournal.com/news/national/2026/10/01/887450.htm"},{"id":"sb:o/f68209638c08c529e4ca43ae","kind":"observation","label":"High Plains Journal · 2026-09-28 · Bayer, Neste agree to scale newgold winter canola for biofuels","url":"https://hpj.com/2026/09/27/newgold-winter-canola-biofuels/"},{"id":"sb:o/56270a717f4af1eddf5921d3","kind":"observation","label":"Business Model Analyst · 2026-09-24 · Grünenthal Paid €375M for a Cancer Drug Bayer Had Outgrown","url":"https://businessmodelanalyst.com/bayer-stivarga-grunenthal-late-life-drug-economics/"},{"id":"sb:o/32940d7cb341edd713a39506","kind":"observation","label":"Opportunities For Africans · 2026-09-23 · The AGNES-BAYER Science Foundation Research Grant 2026 for Biodiversity Conservation & Sustainable Agriculture in Sub-Saharan Africa.","url":"https://www.opportunitiesforafricans.com/the-agnes-bayer-science-foundation-research-grant-2026/"},{"id":"sb:o/21e65ff4f3bd010d6360ce9c","kind":"observation","label":"Brownfield Ag News · 2026-09-23 · Bayer field trials put innovation to the test and farmers in the driver’s seat","url":"https://www.brownfieldagnews.com/news/bayer-field-trials-put-innovation-to-the-test-and-farmers-in-the-drivers-seat/"},{"id":"sb:o/cb3844933bdaa5bbd78a3668","kind":"observation","label":"Fierce Pharma · 2026-09-22 · Bayer offloads cancer drug Stivarga to Grünenthal for up to $431M as new competition looms","url":"https://www.fiercepharma.com/pharma/bayer-offloads-cancer-drug-stivarga-grunenthal-431m-new-competition-looms"},{"id":"sb:o/ba6e336e63dbc38a8566ed12","kind":"observation","label":"AgFunderNews · 2026-09-18 · Robigo Bio eyes commercialization for its ag biologicals with Leaps by Bayer investment","url":"https://agfundernews.com/robigo-bio-eyes-commercialization-for-its-ag-biologicals-with-leaps-by-bayer-investment"}],"cursor":null,"order":"newest first; we keep the 10 newest receipts for this entity whose own headline names it. Its other observations are counted in standing.evidence.supporting but are not addressable in v1"},"relations":{"count":10,"byKind":{"co-mentioned":10},"items":[{"kind":"relation","label":"co-mentioned with ai (21 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/381c9edf2fd8cb925f1a6a6d"},{"kind":"relation","label":"co-mentioned with europe (21 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/a374186a6fa56cf53a888ffe"},{"kind":"relation","label":"co-mentioned with studie (21 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/6600f94348e07b521efe8ba4"},{"kind":"relation","label":"co-mentioned with germany (20 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/a34bf42b8a2138a0840cc275"},{"kind":"relation","label":"co-mentioned with china (19 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/503e95399787890361f02777"},{"kind":"relation","label":"co-mentioned with amgen (18 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/92c961c97b5daa296e8839cf"},{"kind":"relation","label":"co-mentioned with fda (17 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/7f5c0d130e04ffa4bbd2af83"},{"kind":"relation","label":"co-mentioned with eli lilly (16 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/7fd078cbd98d833413ab6feb"},{"kind":"relation","label":"co-mentioned with merck (16 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/78b616db52882defb4b705e7"},{"kind":"relation","label":"co-mentioned with united states (16 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/7a2bc684df1c28aeb4ba032d"}],"cursor":null,"order":"situations first, then claims (the subject's own maintained record, then site-wide corroborated clusters; each label ends with its standing), then co-mentions by shared documents, descending. Co-mentions are the ten strongest the entity graph keeps per entity"},"edge":{"state":"continues"},"links":{"rest":"/api/v1/node/e/1ee53d41c55e54b636a128d0","mcp":"traverse {\"id\":\"sb:e/1ee53d41c55e54b636a128d0\"}","page":"/entity/bayer/"},"limits":{"levelsPerCall":1,"pageSize":10,"maxPageSize":50,"membersMax":50,"statement":"One level per call: depth is 1 and only 1, and there is no whole-graph dump. pageSize 1-50 (default 10); a page limit is a cursor, never an edge. Members are listed up to 50. At most 60 traverse calls a minute per caller (runaway-loop protection, not a meter). One knowledge cutoff is served: the deploy's."},"actions":[{"verb":"unfold","lit":true,"effect":"read","layer":"cantina","call":"traverse {\"id\":\"sb:e/1ee53d41c55e54b636a128d0\",\"level\":\"children\"}"},{"verb":"fold","lit":true,"effect":"read","layer":"cantina","call":"traverse {\"id\":\"sb:e/1ee53d41c55e54b636a128d0\"}"},{"verb":"panOut","lit":false,"effect":"read","layer":"cantina","reason":"An entity is a root: it is contained by nothing. Pan out by following R."},{"verb":"follow","lit":true,"effect":"read","layer":"cantina","call":"traverse {\"id\":\"sb:e/1ee53d41c55e54b636a128d0\",\"level\":\"relations\"}"},{"verb":"receipts","lit":false,"effect":"read","layer":"cantina","reason":"receipts are the observations below this node; unfold to reach them"},{"verb":"edge","lit":true,"effect":"read","layer":"cantina","call":"traverse {\"id\":\"sb:e/1ee53d41c55e54b636a128d0\"}"},{"verb":"asOf","lit":false,"effect":"read","layer":"cantina","reason":"v1 serves one knowledge cutoff, this deploy's; walking an earlier cutoff needs retained history (EQ-REPLAY), which v1 does not keep"},{"verb":"switchObserver","lit":false,"effect":"read","layer":"cantina","reason":"the public record is the same for every observer; traversal through a Watch's lens is not served in v1"},{"verb":"readOriginal","lit":false,"effect":"read","layer":"cantina","reason":"no translation is applied on this node; every label is the source's own text"},{"verb":"save","lit":false,"effect":"watch-declaration","layer":"workshop","reason":"saving applies to a configured Watch; configure one around this node first (free), then save it"},{"verb":"deliver","lit":false,"effect":"watch-declaration","layer":"workshop","reason":"delivery applies to a saved Watch"},{"verb":"format","lit":false,"effect":"watch-declaration","layer":"workshop","reason":"output format applies to a saved Watch"},{"verb":"deltaR","lit":false,"effect":"read","layer":"workshop","reason":"Delta R needs a saved Watch with a previous reading"},{"verb":"read","lit":false,"effect":"read","layer":"docking-bay","reason":"one-time Reads are parked until the Commander decides their shape (#938)"}]}